KB

Kaushik Balakrishnan Natesan

Active Director Cfo DIN 08299186
DIN 08299186 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 20 historical roles
Total affiliations 22 Since Mar 2019
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 06 Mar 2019
Active appointments 5
Total timeline records 22

Kaushik Balakrishnan Natesan (DIN 08299186) has 22 recorded board appointments in Indian companies, the first from March 2019, of which 5 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2019
Entero Healthcare Solutions Limited Cfo · 2025 – present
Current
Zennx Software Solutions Private Limited Director · 2021 – present
Current
Curever Pharma Private Limited Director · 2021 – present
Current
Quromed Lifesciences Private Limited Director · 2020 – present
Current
Rimedio Pharma Private Limited Director · 2020 – present
Current
Entero R.S. Enterprises Private Limited Director · 2023 – 2025
Previous
Previous
Svmed Solutions Private Limited Director · 2023 – 2025
Previous
Svs Lifesciences Private Limited Director · 2022 – 2023
Previous
Previous
Previous
R S M Pharma Private Limited Director · 2021 – 2023
Previous
Previous
Previous
Chethana Pharma Private Limited Director · 2021 – 2023
Previous
Previous
Previous
Calcutta Medisolutions Private Limited Director · 2021 – 2023
Previous
Previous
Previous
Galaxystar Pharma Distributors Private Limited Additional Director · 2019 – 2019
Previous
Sundarlal Pharma Distributors Private Limited Additional Director · 2019 – 2019
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available